Compare KLA Corp. (KLAC) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KLA Corp. vs Sana Biotechnology Inc — how do they compare? KLA Corp. trades at $216.98 (market cap $271.18B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: KLA Corp. is far larger — about 310.3× Sana Biotechnology Inc's market cap, and KLA Corp. pays a 0.44% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| KLAC | SANA | |
|---|---|---|
Market Cap | $271.18B | $873.84M |
Sector | Technology | Health |
52-Week High | $301.71 | $5.92 |
52-Week Low | $84.39 | $2.68 |
Enterprise Value | $272.37B | $848.03M |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KLA Corporation (KLAC) trades at $217.56, up 2.26% today, showing strong momentum after recent earnings beats. The stock maintains bullish technical signals with RSI levels indicating potential oversold conditions. Fundamentally, KLAC demonstrates robust profitability with 35.66% net income margin and consistent revenue growth, though valuation ratios remain elevated. Recent corporate actions include a 1:10 stock split and $2.30 dividend payment, reflecting management confidence.
KLAC presents a compelling growth story with dominant semiconductor process control positioning, but faces valuation concerns and sector volatility risks. Analyst consensus remains bullish with $242.49 price target, though near-term headwinds from semiconductor market correction require careful monitoring. The company's strong cash flow generation and AI-driven equipment demand support long-term upside potential.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KLA Corp.
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
